SUBSCRIBE
SUBSCRIBE

Northstar Medical Radiosotopes

IN THE PRESS
Press Releases
NorthStar Medical Radioisotopes to Participate in October 2024 Oppenheimer Conference
October 3, 2024
 · 
2 min read
BioMidwest
NorthStar Medical Radioisotopes Marks Critical Milestone in Readiness for Clinical Batch Production
June 4, 2024
 · 
6 min read
BioMidwest
NorthStar Medical Radioisotopes, LLC Enters Clinical Supply Agreement to Support Clarity Cu-67 SAR-bisPSMA Pivotal Trials
April 10, 2024
 · 
4 min read
BioMidwest
NorthStar Medical Radioisotopes Announces Participation in Upcoming 2024 Jefferies Radiopharma Innovation Summit
April 4, 2024
 · 
3 min read
NorthStar Medical Radioisotopes and Alpha-9 Oncology Enter Strategic Long-term Agreement for Supply of Actinium-225 (Ac-225)
January 8, 2024
 · 
5 min read
Business
NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration Agreement for Development and Production of Actinium-225 (Ac-225)-based Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Solid Tumors
January 3, 2024
 · 
5 min read
BioMidwest
NorthStar Medical Radioisotopes Announces Participation in Upcoming 2023 Truist Securities Biopharma Symposium
November 6, 2023
 · 
3 min read
Business
NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)
August 29, 2023
 · 
6 min read
Drug Development
First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma
August 28, 2023
 · 
8 min read
Business
NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer for Therapeutic Radioisotope Actinium-225 (Ac-225)
July 18, 2023
 · 
3 min read
Load More
JOBS